Goldman Sachs analyst Davin Thillainathan initiated coverage of Fisher & Paykel Healthcare with a Buy rating and A$42.70 price target The firm sees an acceleration of revenue in the company’s ...
Shares in Fisher and Paykel Healthcare closed at their second-highest level today, which helped lift the overall New Zealand sharemarket. Photo / Supplied The New Zealand sharemarket ended a ...
Greetings, Our Elliott Wave analysis today updates the Australian Stock Exchange (ASX) FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED – FPH. We see that ASX:FPH stock is about to complete a ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Compendium is an affordable, smart, streamlined data catalog created by and for healthcare professionals. It gives everyone, techie and non-techie alike, a clear picture of what data is available ...